Literature DB >> 4627397

Direct measurement of insulin secretory rate: studies in shocked primates and postoperative patients.

J M Hiebert, J M McCormick, R H Egdahl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4627397      PMCID： PMC1355394          DOI： 10.1097/00000658-197209000-00005

Source DB:  PubMed          Journal:  Ann Surg        ISSN： 0003-4932            Impact factor:   12.969


× No keyword cloud information.
  24 in total

1.  Intravenous glucose-tolerance, insulin, and free-fatty-acid levels in burned patients.

Authors:  S P Allison; P Hinton; M J Chamberlain
Journal:  Lancet       Date:  1968-11-23       Impact factor: 79.321

2.  Simultaneous measurements of hepatic and portal venous blood flow in the sheep and dog.

Authors:  M L Katz; E N Bergman
Journal:  Am J Physiol       Date:  1969-04

3.  The practicality of umbilical vein cannulation in patients with and without portal hypertension.

Authors:  F W Braastad; D C Wukasch; P H Jordan
Journal:  Arch Surg       Date:  1970-07

4.  Portal and peripheral vein immunoreactive insulin concentrations before and after glucose infusion.

Authors:  W G Blackard; N C Nelson
Journal:  Diabetes       Date:  1970-05       Impact factor: 9.461

5.  Blood sugar and insulin response of humans in shock.

Authors:  L C Carey; B D Lowery; C T Cloutier
Journal:  Ann Surg       Date:  1970-09       Impact factor: 12.969

6.  Insulin response during hypovolemic shock.

Authors:  W E Bauer; S N Vigas; R E Haist; W R Drucker
Journal:  Surgery       Date:  1969-07       Impact factor: 3.982

7.  Critical variables in the radioimmunoassay of serum insulin using the double antibody technic.

Authors:  J S Soeldner; D Slone
Journal:  Diabetes       Date:  1965-12       Impact factor: 9.461

8.  Serum insulin and growth hormone response to hemorrhagic shock.

Authors:  G M Cerchio; G S Moss; P A Popovich; E Butler; D C Siegel
Journal:  Endocrinology       Date:  1971-01       Impact factor: 4.736

9.  Evaluation of anticancer drugs by umbilical vein hepatography.

Authors:  R E Kessler; F Ramos-Yordan
Journal:  Cancer       Date:  1967-02       Impact factor: 6.860

10.  Blood glucose and serum insulin in reversible and irreversible posthemorrhagic shock.

Authors:  D F Halmagyi; D J Gillett; L Lazarus; J D Young
Journal:  J Trauma       Date:  1966-09
View more
  8 in total

1.  [Glucose tolerance and insulin secretion in oral and intravenous glucose load after intraabdominal operation (author's transl)].

Authors:  R Bittner; H G Beger; R Roscher; E Kraas
Journal:  Langenbecks Arch Chir       Date:  1975

2.  [Glucose-assimilation and dynamics of insulin secretion. Measurements after intra-abdominal operations (author's transl)].

Authors:  R Bittner; H G Beger; E Kraas; R Roscher
Journal:  Klin Wochenschr       Date:  1975-09-15

3.  Calculation of net insulin secretion and pancreatic blood flow.

Authors:  N M Bor; M T Ercan; M Alvur; C Bekdik; G Oner
Journal:  Pflugers Arch       Date:  1974       Impact factor: 3.657

4.  Energy metabolism in sepsis: treatment based on different patterns in shock and high output stage.

Authors:  G H Clowes; T F O'Donnell; N T Ryan; G L Blackburn
Journal:  Ann Surg       Date:  1974-05       Impact factor: 12.969

5.  Estimation of pancreatic IRI output rate and its relations to glucose tolerance in normal anasthetized dogs.

Authors:  U Fischer; H Hommel; P Heinke; E Jutzi
Journal:  Diabetologia       Date:  1975-08       Impact factor: 10.122

Review 6.  Hormonal changes and their influence on metabolism and nutrition in the critically ill.

Authors:  M S Dahn; P Lange
Journal:  Intensive Care Med       Date:  1982       Impact factor: 17.440

7.  Pancreatic blood flow in conscious dogs after oral administration of glucose.

Authors:  U Fischer; H Hommel; E Salzsieder
Journal:  Diabetologia       Date:  1976-05       Impact factor: 10.122

8.  Factors affecting the plasma insulin concentration shortly after accidental injury in man.

Authors:  K N Frayn; P F Maycock; R A Little; D W Yates; H B Stoner
Journal:  Arch Emerg Med       Date:  1987-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.